# Gain Therapeutics (GANX) — Analyst Forecast

GANX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ganx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 5, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Aug 31, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Aug 11, 2026 | BTIG | Maintained | Buy | $5.00 |
| Jul 1, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jun 30, 2026 | BTIG | Maintained | Buy | $5.00 |
| Dec 19, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Oct 15, 2025 | BTIG | Maintained | Buy | $9.00 |
| Oct 13, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Oct 7, 2025 | Maxim Group | Maintained | Buy | $7.00 |
| Sep 8, 2025 | BTIG | Maintained | Buy | $9.00 |
| Aug 13, 2025 | Roth Capital | Maintained | Buy | $6.00 |
| Jul 3, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| May 19, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Mar 28, 2025 | Chardan Capital | Maintained | Buy | $6.00 |
| Mar 17, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Mar 7, 2025 | Scotiabank | Initiated Coverage | Sector Outperform | $12.00 |
| Dec 24, 2024 | Roth MKM | Maintained | Buy | $7.00 |
| Dec 5, 2024 | Roth MKM | Initiated Coverage | Buy | $7.00 |
| Nov 25, 2024 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Oct 9, 2024 | HC Wainwright & Co. | Maintained | Buy | $8.00 |

## Frequently Asked Questions

### Is GANX a buy, sell, or hold?

Analysts covering Gain Therapeutics currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on GANX?

On Oct 5, 2026, HC Wainwright & Co. maintained Gain Therapeutics at Buy with a price target of $8.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).